Sign in
Intravitreal Gene Therapy for Neovascular AMD With ADVM-022: Results of the Phase 1 OPTIC Trial
Charles C Wykoff, MD, PhD, FASRS
Updates from the Field
2020
Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy: Phase II ALTITUDE Study
Annual Meeting Talks
2022
Higher-Order Optical Coherence Tomography Fluid Burden Assessment: Analysis From the OSPREY Trial
Justis P. Ehlers, MD, FASRS
2019
Category: AMD-Neovascular